J&J's diversified growth, strong pipeline, and robust balance sheet position it as a steadier long-term pick over Merck's Keytruda-dependent outlook.

Chipotle's third-quarter setup shows strong marketing and digital traction, but weak consumer sentiment and high costs may cloud results.

GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.

TEM secures multiple FDA clearances in 2025, boosting its AI-driven diagnostic portfolio across oncology and cardiology.

The gold market continues to see a lot of noisy trading on Monday, as we are likely to see a bit of exhaustion as the main factor here. Also, this is a situation where there are value hunters out there, so the “buy on the dip” crowd is still out

America's oil magnates are prepared for prices to be lower next year, as supply on Texas' Permian Basin ramps up to account for 40% of U.S. oil production in the near future.

Lululemon Athletica Inc (NASDAQ:LULU) shares rose nearly 4% in early trading on Monday after the athletic apparel maker announced a partnership with the National Football League (NFL) to create an apparel collection. The collection will be available for sale beginning on October 28 and will feature men's and women's apparel and accessories for all of the NFL's 32 teams.

Procter & Gamble NYSE: PG is a good bet for long-term total returns because its stock price is near the low end of its historical P/E range, its yield is near the high end of its range, and its FQ1 2026 results affirm its outlook for growth, cash flow, and capital returns.

Investors need to pay close attention to KEYS stock based on the movements in the options market lately.

Explore how Amphenol's (APH) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Standard Motor Products (SMP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top-and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Universal Insurance (UVE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Review Equifax's (EFX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

The crude oil market continues to see a lot of noise, as we are trying to sort out the situation with the Russian sanctions and the possibility of a lack of demand around the world. With this in mind, it isn't a surprise that the market is drifting.

Powell Industries (POWL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Quanta Services (PWR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of Altria (MO) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Supernus (SUPN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Examine the evolution of Teledyne's (TDY) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.